Ownership and Options
Ownership and Options
Molina passes the tradability test a value buyer applies before anything else: the NYSE-listed shares trade roughly $240 million a day, and listed options run out to January 2028, giving a defined-risk way to hold the recovery for more than a year. The cost of that access is high. Implied volatility sits near 50% — about double a stable insurer's — so that optionality is expensive, and the people best placed to signal conviction are quiet: no insider has bought in the open market since 2018, the buyback paused, and the average sell-side target is below the price.
The equity: liquid, ownable, and a weak long-run hold
Share Price (Jul 16 2026)
52-Week Low
52-Week High
Avg Daily Volume ($M, 20d)
Source: 52-week levels and average daily volume derived from daily price data through Jul 16 2026; NYSE listing per FY2025 Annual Report (Form 10-K), Item 5 [1].
Liquidity is not a constraint here. The stock turns over about 700% of its float a year, roughly $240 million changes hands on an average day — near 2% of market value — and a position worth 1% of the company (about $126 million) could be exited in three to six days at a fifth of daily volume. A value investor can build or unwind a meaningful stake without moving the price. The shares list on the New York Stock Exchange as "MOH", there are 14 registered holders of record, and the company has never paid a cash dividend [2] — total return is entirely price and buybacks, with no coupon to wait in.
That return has been poor over the cycle. $100 invested in Molina at the end of 2020 was worth $80 at the end of 2025; the same $100 in the S&P 500 grew to $195, and in the company's own peer group to $160 [3].
Source: FY2025 Annual Report (Form 10-K), Stock Performance Graph, five-year cumulative total return [4].
The line tells the two-act story the rest of this report dissects: a top-decile compounder into 2023, then a round-trip that gave back five years of relative performance in the 2024–2025 margin break. By that arithmetic the shares have already fallen — $100 invested at end-2020 was worth $80 at end-2025 — rather than sitting at a demanding valuation.
Options: the universe gate clears, but volatility is richly priced
Molina carries a full listed-options market, and the longest-dated contracts extend to January 15, 2027 and January 21, 2028 — the latter roughly eighteen months out. Long-dated, at-the-money options beyond one year exist, so the position can be expressed with defined downside rather than only in the common. On availability, the name fits a mandate that requires liquid, long-dated optionality.
The price of that optionality is high. Molina's shares have realized about 42% annualized volatility over the past month, and the term structure of implied volatility sits above even that: roughly 53% at the four-month tenor and in the mid-60s for the nearest expiry, the latter lifted by second-quarter results due in late July.
Source: realized 30-day volatility derived from daily price data; historical and implied volatility per third-party options data (AlphaQuery), as of Jul 16 2026.
A stable managed-care name would typically carry implied volatility in the 25–30% range; Molina's is close to double that. The options market is pricing continued large moves — the same unresolved question the margin work leaves open (Margin Reset): whether 2025 was a step-change or a dislocation. For the buyer, that means a January 2028 call to hold the recovery is available and defined-risk, but the premium embeds roughly 50% annualized volatility, so a large move in the stock is needed just to clear the cost of carry. The optionality is a genuine tool, not a cheap one.
One caveat on precision: exact at-the-money open interest and bid-ask spreads for each expiry require a live options terminal and are not in the source record. The read on tradability rests on the depth of the underlying — a stock trading $240 million a day almost always supports liquid at-the-money strikes — and on the confirmed presence of the 2027 and 2028 expirations. Reported options positioning is not one-sided: the put-to-call ratio on open interest is about 0.65, so the book is not heavily skewed toward downside protection.
Who is buying — and who is not
For a reader who treats management's own money and the buyback as conviction signals, Molina offers little confirmation at the lows.
Insiders have not bought a share in the open market since 2018. Through the entire 2024–2025 drawdown — including the trade to a 52-week low of $122.65 — Form 4 filings show grants, tax-withholding, and option mechanics, but no discretionary open-market purchases, and only about $3.5 million of open-market selling in 2025–2026. There was no insider capitulation, but there was also no one stepping in to buy the collapse.
The buyback tells a sharper version of the same story. Molina returned $1.0 billion through repurchases in each of 2024 and 2025, but in the fourth quarter of 2025 — with the stock trading between roughly $145 and $193 — it made no repurchases under its program, withholding only 1,300 shares to settle employee tax obligations [5]. The company did not lean into the weakest prices of the year, consistent with the parent-cash constraint detailed in Valuation and Buybacks rather than with opportunistic buying.
Watch item: a resumption of repurchases into weakness — capacity permitting, as detailed in Valuation and Buybacks — would be the clearest management-conviction signal available.
The sell-side is neutral to cool. Of 19 analysts, 3 rate the stock a buy, 15 a hold, and 1 a strong sell; the average price target of $210.76 (median $209) sits about 6% below the $224.82 price, within a wide $129–$286 range.
Source: consensus analyst ratings, as of Jul 2026.
Last Price
Mean Target
High Target
Low Target
Source: consensus price targets (19 analysts), as of Jul 2026.
Underneath the ratings, the estimate revisions match the "priced as a recovery" frame from the valuation work (Valuation and Buybacks): over the past 90 days the Street cut its 2026 EPS estimate from about $5.53 to $5.16 while lifting 2027 from about $5.77 to $8.34. Analysts are marking down the trough year and marking up the rebound — pricing the recovery, not the present. Reported short interest is not available in the source record, so the crowded-short question cannot be answered from what is on file.
What the positioning adds up to
The tradability box is checked: a value investor can own Molina in size and can express the view through January 2028 options with defined risk. What positioning does not offer is a cheap tailwind. Implied volatility near 50% means the option market demands a rich premium for exactly the uncertainty this report has been weighing; insiders are not buying the lows; the buyback stepped aside at the weakest prices; and the median analyst target sits below the last trade. A buyer here is early and largely unaccompanied, underwriting the earnings recovery against a market that is still pricing continued volatility rather than resolution.
Three things would change that read, each checkable: implied volatility compressing back toward the stock's realized level and a normal insurer's 25–30% as margin visibility returns; open-market insider buying or a resumed buyback into weakness; and sell-side targets moving above the price. None has happened yet.